Seasoned healthcare experts join Jack Morton’s expanding healthcare practice; company promotes and hires other key individuals.
The FDA’s Obstetrics Reproductive and Urologic Drugs Advisory Committee voted nearly unanimously to withdraw the approval of Covis’ preterm birth drug Makenna.
We cannot underestimate the negative impact – not only on individual lives but also on wider society – of participant populations not being proportionately represented in clinical trials.
The deal augments Indegene’s commercialization portfolio spanning drug discovery and development to marketing and sales, adding brand strategy and market development capabilities along with patient engagement platforms.
Merck KGaA said it had been placed under formal investigation by a French court for possibly issuing misleading information regarding its thyroid drug product Levothyrox.
Elevalt’s 4Ps proprietary algorithms are the culmination of six years of refining omnichannel execution and are the foundation of the company’s data-driven approach to commercialization.
NYF Health launches Future Now Categories, NYF Health DE&I Advisory Board, and Multiple Special Industry Awards.
Schappell and Warker join the leader in social health to accelerate innovation, position the company for exponential growth.
Through this new partnership, marketers and brands will have off-the-shelf and privacy-optimized access to key consumer groups.
Understanding and applying health literacy principles is about empowering people to find, discern, and use information to improve their own health, or the health of those they care for. Clear communication, achieved with the support of health literacy principles, makes healthcare spaces more equitable and accessible for everyone.